Expand GRI Menu
GRI MENU

GRI Latest Press Releases

-- April 8, 2026 --

GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Inflammatory Conditions Globe Newswire 8:30 AM

-- February 17, 2026 --

GRI Bio CEO, Marc Hertz, Featured in Virtual Investor "What This Means" Segment Globe Newswire 9:15 AM

-- February 9, 2026 --

JTC Team Companies to Present in Webull Corporate Connect Webinar Series Happening February 10-11, 2026 ACCESS Newswire 11:30 AM

-- February 5, 2026 --

GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial Globe Newswire 9:15 AM

-- February 4, 2026 --

GRI Bio Reiterates Full Year 2025 Financial Results, Strengthens Balance Sheet and Summarizes Key Recent Highlights Globe Newswire 8:45 AM

-- January 28, 2026 --

GRI Bio Delivers Compelling New Phase 2a Gene Expression Data Demonstrating Improvements in Key Drivers of Fibrosis and Lung Repair in IPF Globe Newswire 8:45 AM

-- January 26, 2026 --

GRI Bio Secures New U.S. Composition of Matter Patent Covering Novel Compound Structures Globe Newswire 8:30 AM

-- January 21, 2026 --

GRI Bio Announces Reverse Stock Split Globe Newswire 4:01 PM

-- January 8, 2026 --

GRI Bio Announces Additional Positive Data from Phase 2a Study in Idiopathic Pulmonary Fibrosis, Strengthening Clinical Proof-of-Concept for GRI-0621 Globe Newswire 8:00 AM

-- December 12, 2025 --

GRI Bio Announces Closing of $8.0 Million Public Offering Globe Newswire 4:05 PM

-- December 11, 2025 --

GRI Bio Announces Pricing of $8,000,000 Million Public Offering Globe Newswire 9:15 AM

-- December 10, 2025 --

GRI Bio Announces Positive Topline Data from its Phase 2a Study in Idiopathic Pulmonary Fibrosis ("IPF") Globe Newswire 4:05 PM
Market Data Delayed 15 Minutes